DOI: 10.36347/sjams.2013.v01i06.0108

Pages: 1177-1180

Background: Cervical cancer is one of the main causes of cancer death in women, most of which is caused by human papillomavirus (HPV) infection. Approximately 86% of women who die from cervical cancer are in developing countries. Uterine cervical cancer is the most common gynecologic malignancy and the second most common cancer in women worldwide in terms of incidence and mortality. The present study was conducted to assess MR imaging staging in uterine cervical carcinoma. Methods: This prospective study was conducted on 120 patients visited to the Dept. of Radiology & Imaging, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh July 2012 to June 2013. Total 120 patients of neoplastic etiology involving endocervix. All patients diagnosed as having uterine cervical carcinoma were included in this study. All were informed regarding the study and their consent was obtained. Results: Total 120 patients of neoplastic etiology involving endocervix. MRI showed high rate of detection (96.7%) as compared to CT scan and USG with failure of detection only in lesion staged Ia1 or Ia2 which represents microscopic involvement of carcinoma of cervix. CT scan was able to detect nodes in 80% cases. USG failed to demonstrate enlarged nodes in 6 cases. Maximum stage was IV seen in 21% followed by IIb in 20% and Ib2 in 16%. The difference was significant (p< 0.05). Conclusion: In patients with cervical cancer, pretreatment MRI provides higher spatial soft tissue resolution which can define pelvic tumor extent, including a more accurate assessment of tumor size (due to multiplanar evaluation), parametrial invasion, pelvic sidewall invasion, and adjacent pelvic organ invasion. Authors found that MRI is highly sensitive in detection of early stage of carcinoma of cervix.